Practice of Door-to-Door Delivery Service of Peritoneal Dialysate
Objective To provide ideas for door-to-door delivery of peritoneal dialysate and pharmaceutical care.Methods A survey questionnaire was designed to conduct on-site survey or telephone follow-up on 152 patients who chose to door-to-door delivery of peritoneal dialysate from June 2021 to December 2023 in the hospital.The satisfaction with the door-to-door delivery service of peritoneal dialysate,the situation of drug management during home peritoneal dialysis,occurrence of adverse drug reactions(ADRs),and medication education were surveyed.Results Among the 152 surveyed patients,29 cases(19.08%)had peritoneal dialysis duration within six months,61 cases(40.13%)had peritoneal dialysis duration between six months and two years,and 62 cases(40.79%)had peritoneal dialysis duration over two years.A total of 147 cases(96.71%)had a satisfaction score of 10 points for the door-to-door delivery service of peritoneal dialysate.A total of 122 cases(80.26%)were able to store peritoneal dialysate in a standardized manner;a total of 102 cases(67.11%)were able to operate peritoneal dialysate in a standardized and correct manner;a total of 114 cases(75.00%)knew the dosing sequence of peritoneal dialysate and were able to operate it correctly.A total of 92 cases(60.53%)had ADR during home peritoneal dialysis,with the highest incidence rate being solvent-related ADR(46.05%),and the main methods for handling ADR were to consult with physicians(96.71%)and nurses(49.34%);a total of 134 cases(88.16%)knew all medication precautions;a total of 145 patients(95.39%)had a demand for pharmaceutical care,with the highest demand rate being ADR treatment methods(70.39%).The non-parametric rank sum test results showed that the incidence of ADR in patients with dialysis duration over six months was significantly higher than that in patients with dialysis duration within six months(χ2=22.494,P<0.001).Conclusion The patients had a high satisfaction with the door-to-door delivery service of peritoneal dialysate,some patients have non-standard use and storage of peritoneal dialysate,and most patients have experienced ADR during home peritoneal dialysis.Patients underwent peritoneal dialysis have a high demand for pharmaceutical care,pharmacists can carry out home pharmaceutical care such as handling ADR and improving medication compliance to promote safe and rational drug use.
peritoneal dialysatedoor-to-door deliveryhome pharmaceutical care
万方数据
维普
